calcium carbonate 800 MG / famotidine 10 MG / magnesium hydroxide 165 MG [Duo Fusion]
- RxCUI
- 1744393
- RxNorm name
- calcium carbonate 800 MG / famotidine 10 MG / magnesium hydroxide 165 MG [Duo Fusion]
- Term type
- SBDC
- Status
- Active
- Updated
- 2026-10-29 07:11:52
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042016
- Active start
- 042016
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 800 MG / 1 EACH | calcium carbonate | ||
| 10 MG / 1 EACH | famotidine | ||
| 165 MG / 1 EACH | magnesium hydroxide |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| calcium carbonate | 1897 |
| famotidine | 4278 |
| magnesium hydroxide | 6581 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | calcium carbonate 800 MG / famotidine 10 MG / magnesium hydroxide 165 MG [Duo Fusion] | 1 | NAMES |
| RxNorm Name | calcium carbonate 800 MG / famotidine 10 MG / magnesium hydroxide 165 MG [Duo Fusion] | 1 | NAMES |
| TTY | SBDC | 1 | ATTRIBUTES |
| RxCUI | 1744393 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A12AA | Calcium | ATC1-4 | calcium carbonate | |
| ATC | A02AC | Calcium compounds | ATC1-4 | calcium carbonate | |
| ATC | A02BA | H2-receptor antagonists | ATC1-4 | famotidine | |
| ATC | A02AA | Magnesium compounds | ATC1-4 | magnesium hydroxide | |
| ATC | G04BX | Other urologicals | ATC1-4 | magnesium hydroxide | |
| FDASPL | N0000175784 | Histamine-2 Receptor Antagonist | EPC | has_epc | famotidine |
| FDASPL | N0000000151 | Histamine H2 Receptor Antagonists | MOA | has_moa | famotidine |
| MEDRT | D002119 | Calcium Carbonate | CHEM | has_ingredient | calcium carbonate |
| MEDRT | D015738 | Famotidine | CHEM | has_ingredient | famotidine |
| MEDRT | D008276 | Magnesium Hydroxide | CHEM | has_ingredient | magnesium hydroxide |
| MEDRT | D001064 | Appendicitis | DISEASE | ci_with | magnesium hydroxide |
| MEDRT | D003248 | Constipation | DISEASE | may_treat | magnesium hydroxide |
| MEDRT | D003680 | Deglutition Disorders | DISEASE | ci_with | famotidine |
| MEDRT | D003967 | Diarrhea | DISEASE | induces | magnesium hydroxide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | magnesium hydroxide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | calcium carbonate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | famotidine |
| MEDRT | D004381 | Duodenal Ulcer | DISEASE | may_treat | magnesium hydroxide |
| MEDRT | D004381 | Duodenal Ulcer | DISEASE | may_treat | famotidine |
| MEDRT | D004381 | Duodenal Ulcer | DISEASE | may_prevent | famotidine |
| MEDRT | D004381 | Duodenal Ulcer | DISEASE | may_treat | calcium carbonate |
| MEDRT | D004415 | Dyspepsia | DISEASE | may_treat | famotidine |
| MEDRT | D004415 | Dyspepsia | DISEASE | may_treat | magnesium hydroxide |
| MEDRT | D004415 | Dyspepsia | DISEASE | may_treat | calcium carbonate |
| MEDRT | D004942 | Esophagitis, Peptic | DISEASE | may_treat | famotidine |
| MEDRT | D004942 | Esophagitis, Peptic | DISEASE | may_treat | magnesium hydroxide |
| MEDRT | D004942 | Esophagitis, Peptic | DISEASE | may_treat | calcium carbonate |
| MEDRT | D005244 | Fecal Impaction | DISEASE | ci_with | magnesium hydroxide |
| MEDRT | D005764 | Gastroesophageal Reflux | DISEASE | may_treat | famotidine |
| MEDRT | D005764 | Gastroesophageal Reflux | DISEASE | may_treat | magnesium hydroxide |
| MEDRT | D005764 | Gastroesophageal Reflux | DISEASE | may_treat | calcium carbonate |
| MEDRT | D006471 | Gastrointestinal Hemorrhage | DISEASE | may_treat | calcium carbonate |
| MEDRT | D006471 | Gastrointestinal Hemorrhage | DISEASE | may_treat | magnesium hydroxide |
| MEDRT | D006471 | Gastrointestinal Hemorrhage | DISEASE | may_prevent | calcium carbonate |
| MEDRT | D006471 | Gastrointestinal Hemorrhage | DISEASE | may_prevent | magnesium hydroxide |
| MEDRT | D006471 | Gastrointestinal Hemorrhage | DISEASE | may_prevent | famotidine |
| MEDRT | D006327 | Heart Block | DISEASE | ci_with | magnesium hydroxide |
| MEDRT | D006356 | Heartburn | DISEASE | may_treat | famotidine |
| MEDRT | D006356 | Heartburn | DISEASE | may_treat | magnesium hydroxide |
| MEDRT | D006356 | Heartburn | DISEASE | may_treat | calcium carbonate |
| MEDRT | D016481 | Helicobacter Infections | DISEASE | may_treat | famotidine |
| MEDRT | D006505 | Hepatitis | DISEASE | ci_with | magnesium hydroxide |
| MEDRT | D006934 | Hypercalcemia | DISEASE | ci_with | calcium carbonate |
| MEDRT | D006996 | Hypocalcemia | DISEASE | may_treat | calcium carbonate |
| MEDRT | D017674 | Hypophosphatemia | DISEASE | ci_with | calcium carbonate |
| MEDRT | D007669 | Kidney Calculi | DISEASE | ci_with | calcium carbonate |
| MEDRT | D007676 | Kidney Failure, Chronic | DISEASE | may_treat | magnesium hydroxide |
| MEDRT | D007676 | Kidney Failure, Chronic | DISEASE | may_treat | calcium carbonate |
| MEDRT | D008275 | Magnesium Deficiency | DISEASE | may_prevent | magnesium hydroxide |
| MEDRT | D008275 | Magnesium Deficiency | DISEASE | may_treat | magnesium hydroxide |
| MEDRT | D008659 | Metabolic Diseases | DISEASE | may_treat | magnesium hydroxide |
| MEDRT | D010024 | Osteoporosis | DISEASE | may_prevent | calcium carbonate |
| MEDRT | D015663 | Osteoporosis, Postmenopausal | DISEASE | may_treat | calcium carbonate |
| MEDRT | D051437 | Renal Insufficiency | DISEASE | ci_with | magnesium hydroxide |
| MEDRT | D013276 | Stomach Ulcer | DISEASE | may_treat | calcium carbonate |
| MEDRT | D013276 | Stomach Ulcer | DISEASE | may_treat | famotidine |
| MEDRT | D013276 | Stomach Ulcer | DISEASE | may_prevent | famotidine |
| MEDRT | D013276 | Stomach Ulcer | DISEASE | may_treat | magnesium hydroxide |
| MEDRT | D014581 | Urticaria | DISEASE | may_treat | famotidine |
| MEDRT | D015043 | Zollinger-Ellison Syndrome | DISEASE | may_treat | famotidine |
| MEDRT | N0000000226 | Acid-Base Activity | MOA | has_moa | calcium carbonate |
| MEDRT | N0000000226 | Acid-Base Activity | MOA | has_moa | magnesium hydroxide |
| MEDRT | N0000000220 | Electrolyte Activity | MOA | has_moa | calcium carbonate |
| MEDRT | N0000000220 | Electrolyte Activity | MOA | has_moa | magnesium hydroxide |
| MEDRT | N0000000163 | Enzyme Interactions | MOA | has_moa | magnesium hydroxide |
| MEDRT | N0000000151 | Histamine H2 Receptor Antagonists | MOA | has_moa | famotidine |
| MEDRT | N0000010288 | Osmotic Activity | MOA | has_moa | magnesium hydroxide |
| MEDRT | N0000008312 | Bone Resorption Alteration | PE | has_pe | calcium carbonate |
| MEDRT | N0000008337 | Cellular Activity Alteration | PE | has_pe | magnesium hydroxide |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | famotidine |
| MEDRT | N0000009054 | Gastric Acid Alteration | PE | has_pe | calcium carbonate |
| MEDRT | N0000009054 | Gastric Acid Alteration | PE | has_pe | magnesium hydroxide |
| MEDRT | N0000009557 | Increased Renal PO4-- Excretion | PE | has_pe | calcium carbonate |
| MEDRT | N0000009724 | Inhibition Gastric Acid Secretion | PE | has_pe | famotidine |
| MEDRT | N0000009845 | Small Intestine Fluid/Electrolyte Absorption Alteration | PE | has_pe | magnesium hydroxide |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |